| 000 | 00912nam a22002777a 4500 | ||
|---|---|---|---|
| 001 | D0001B001775 | ||
| 003 | DOH | ||
| 005 | 20210123145556.0 | ||
| 008 | 210123b ||||| |||| 00| 0 eng d | ||
| 020 | _a9789241209878 | ||
| 040 | _erda | ||
| 245 | 0 | 0 | _aWHO Expert Committee on Biological Standardization, sixty-fourth report |
| 260 |
_aGeneva : _bWHO, _c2014. |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarier _avolume |
||
| 490 |
_aWHO technical report series ; _v987 |
||
| 650 | 2 | _aBiological Products | |
| 650 | 2 | _aVaccines | |
| 650 | 2 | _aReference Standards | |
| 650 | 2 | _aGuideline | |
| 710 | 2 | _aWorld Health Organization | |
| 711 | 2 |
_aWHO Expert Committee on Biological Standardization _d(2013 : _cGeneva, Switzerland) |
|
| 856 | _uhttps://apps.who.int/iris/bitstream/handle/10665/129494/TRS_987_eng.pdf?sequence=1&isAllowed=y | ||
| 942 |
_2nlm _cBK |
||
| 999 |
_c2504 _d2504 |
||